Daisy
Daisy Carbajal Quintana, Habana CU
Patent application number | Description | Published |
---|---|---|
20100021574 | Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis from the Royal Palm (Roystonea regia) Fruits - A method for obtaining a pharmaceutical composition from | 01-28-2010 |
20100022649 | Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis From the Royal Palm (Roystonea regia) Fruits - A method for treating and/or preventing BPH prostatitis, alopecia and hirsutism including administering a medication of the pharmaceutical composition obtained from the green or mature fruits of | 01-28-2010 |
Daisy Curbeon, New York, NY US
Patent application number | Description | Published |
---|---|---|
20150257469 | Hair Extension - What is claimed is an natural hair extension. The hair extension is formed with a foundation of an elastic mesh into which wefts of natural hair are sewn. The elastic may also be covered by a ribbon to prevent irritation of the scalp. | 09-17-2015 |
Daisy Cynthia, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20150123696 | METHODOLOGY FOR TESTING INTEGRATED CIRCUITS - An integrated circuit is disclosed. The integrated circuit includes input and output pads, a first integrated circuit portion having first circuitry, and a second integrated circuit portion having second circuitry different from the first circuitry. The first integrated circuit portion is configured to provide an input test signal from the input pad to the second integrated circuit portion, and provide an output test signal from the second integrated circuit portion to the output pad, the output test signal being generated by second integrated circuit portion in response to the input test signal. | 05-07-2015 |
Daisy Daivasagay, Montreal CA
Patent application number | Description | Published |
---|---|---|
20140080225 | METHODS AND DEVICES FOR XEROGEL BASED SENSORS - Fluorescence based sensing systems and methods that exploit xerogels are provided. Embodiments of the invention encompass a sensing system that includes: an optical excitation source emitting over a first predetermined wavelength range and capable of analog modulation over a predetermined frequency range; a sensor including a gel substrate incorporating within its matrix a receptor for molecular recognition of an analyte and a luminophore for signaling a recognition event relating to the analyte, the luminophore emitting an optical signal over a second predetermined wavelength range; a detection circuit including an optical detector for receiving the optical signal emitted by the luminophore and generating a photocurrent in dependence thereof; an excitation circuit that generates an analog signal for modulating the optical excitation source in dependence upon a digital control; and a read circuit for receiving the photocurrent and generating a digital output. | 03-20-2014 |
Daisy Daivasagaya, Montreal CA
Patent application number | Description | Published |
---|---|---|
20160033413 | METHODS AND DEVICES FOR XEROGEL BASED SENSORS - Chemical sensors today are deployed in massive volumes across multiple industries and yet at the same time they are subject to substantial research and development effort to establish new, faster, lower cost, more accurate, more sensitive chemical sensors. Such sensors and sensor arrays are being exploited across chemistry, biology, clinical biology, environmental science in civilian and military markets. Amongst the many sensor methodologies are xerogel substrates with two moieties, a receptor for molecular recognition of the analyte and a luminophore for signaling the recognition event. In order to fulfill the requirements for low cost there is a requirement for electronic excitation/read circuits that can support architectures with optical source—N sensors—X filters—M detectors, where M≧N and X=N|M. According to embodiments of the invention electronic excitation/read circuits for phase based luminophore sensors are presented that are compatible with single CMOS chip implementation and monolithic integration of the optical excitation/detection elements. | 02-04-2016 |
Daisy Flamez, Lennik BE
Patent application number | Description | Published |
---|---|---|
20100322850 | NEW PLASMA MEMBRANE BIOMARKERS PREFERENTIALLY EXPRESSED IN PANCREATIC BETA CELLS USEFUL IN IMAGING OR TARGETING BETA CELLS - The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. It was selected by a Systems Biology approach on Massively Parallel Signal Sequencing datasets obtained in human islets and Affymetrix microarray datasets on human islets, purified rat primary beta and non beta cells and insulinoma cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1 D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration). The five specific features of the selected biomarkers are: 1) Preferentially expressed in pancreatic islets as compared to surrounding tissues; 2) Higher expression in pancreatic beta cells than in pancreatic alpha cells or than in other islet non-beta cells; 3) Expression levels in pancreatic beta cells are higher or comparable to glucokinase which is an enzyme specifically expressed in the pancreatic beta cell; 4) Located in the membrane and as such targetable with antibodies, peptides or small molecules which allows imaging, targeting and immunohistochemistry; and 5) Expression is not induced during the process of inflammation of the beta cell mass and the protein is not enriched in T-cells and dendritic cells or in other cells participating in the inflammation process. | 12-23-2010 |
Daisy Flamez, Sint-Kwintens-Lennik BE
Patent application number | Description | Published |
---|---|---|
20140105823 | MOLECULES SPECIFICALLY BINDING PANCREATIC BETA CELLS BIOMARKERS - The present invention provides a synthetic peptide molecule that specifically binds an FXYD2-gamma isoform of pancreatic beta cells, said synthetic peptide molecule has 25 amino acids. | 04-17-2014 |
Daisy Ko, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20150307923 | MEGASPHAERA CEREVISIAE SYSTEM PROCESS CONTROL (SPC) PRIMERS, PROBES, AND METHODS - Provided are system process control (SPC) compositions and methods for confirming DNA extraction and PCR amplification of a patient sample through the detection of an introduced control organism, such as | 10-29-2015 |
Daisy Liu, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20130075688 | Semiconductor Memory Device and Manufacturing Method Thereof - A semiconductor memory device includes a first insulating portion. The semiconductor memory device further includes a phase-change material element that contacts the first insulating portion. The semiconductor memory device further includes an electrode that contacts a side surface of the phase-change material element, the side surface of the phase-change material element being not parallel to a top surface of the electrode. The semiconductor memory device further includes a second insulating portion surrounding the phase-change material element. | 03-28-2013 |
20130168633 | SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD THEREOF - A device that may be used for a phase change random access memory in a semiconductor device and a manufacturing method thereof are provided. The device includes a phase change unit and two sidewall electrodes respectively located on two opposite sidewalls of the phase change unit. The phase change unit includes a three layer structure, in which a phase change material layer is positioned between a top insulating material layer and a bottom insulating material layer. The first sidewall electrode and the second sidewall electrode are in contact with two opposite end faces of the phase change material layer. The contact area between electrode and phase change material is reduced, thereby obtaining a relatively small drive current and meeting a demand that the integrated level of such a device is increasingly enhanced. | 07-04-2013 |
20150200359 | SEMICONDUCTOR MEMORY DEVICE AND MANUFACTURING METHOD THEREOF - A semiconductor memory device includes a first insulating portion. The semiconductor memory device further includes a phase-change material element that contacts the first insulating portion. The semiconductor memory device further includes an electrode that contacts a side surface of the phase-change material element, the side surface of the phase-change material element being not parallel to a top surface of the electrode. The semiconductor memory device further includes a second insulating portion surrounding the phase-change material element. | 07-16-2015 |
Daisy Pireh, Lake Forest, IL US
Patent application number | Description | Published |
---|---|---|
20100190822 | Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) - The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases. | 07-29-2010 |
20130059873 | PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) - The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases. | 03-07-2013 |
Daisy Red, Royal Oak, MI US
Patent application number | Description | Published |
---|---|---|
20110137432 | AUTOMATION MANAGEMENT SYSTEM AND METHOD - A method for monitoring performance of at least one task in controlled equipment is disclosed herein. The method includes collecting a series of signals associated with the at least one task, at least some of the signals in the series define timing values for the at least one task. comparing each of at least some of the timing values to a reference value, generating an accumulated variance value based on the comparisons and selectively generating a predictive failure indication based on the generated accumulated variance value. | 06-09-2011 |
Daisy Red, Southfield, MI US
Patent application number | Description | Published |
---|---|---|
20110209321 | MODULAR MANUFACTURING FACILITY AND METHOD - A modular manufacturing facility and method of construction includes a plurality of service and equipment modules which are readily sized and oriented to be packaged, shipped to a desired location, assembled and connected to local resources to form a fully operational assembly or build facility substantially or wholly independent of any resident building structure at the selected site. | 09-01-2011 |
Daisy Riquelme, Somerville, MA US
Patent application number | Description | Published |
---|---|---|
20150079113 | MENA AND ALPHA5 INTEGRIN INTERACTION - Methods are provided for treating invasion of a tumor or metastasis of a tumor in a subject comprising administering to the subject an agent which inhibits the interaction of Mena with an alpha5 integrin. Assays for identifying agents that inhibit interaction of Mena with an alpha5 integrin are also provided. | 03-19-2015 |
Daisy Rutstein, Santa Clara, CA US
Patent application number | Description | Published |
---|---|---|
20150086960 | GUIDING CONSTRUCTION AND VALIDATION OF ASSESSMENT ITEMS - A method for guiding a user in a construction of an assessment item includes identifying a requirement of the assessment item, filtering a plurality of documents in accordance with the requirement to produce a set of relevant documents, presenting a workflow for use in constructing the assessment item, wherein the workflow is based on the set of relevant documents, and presenting a set of questions for use in validating, by the user, that a proposed assessment item meets the requirement. | 03-26-2015 |
Daisy Tan, Toronto CA
Patent application number | Description | Published |
---|---|---|
20090070189 | BUSINESS DOMAIN LEVEL SPECIFICATION OF A MARKETING CAMPAIGN - Embodiments of the present invention address deficiencies of the art in respect to the customer experience marketing component of an e-commerce system and provide a novel and non-obvious method, system and computer program product for specifying marketing campaigns in an e-commerce system at a business domain level. In one embodiment of the invention, a method for specifying marketing campaigns in an e-commerce system at a business domain level can include specifying criteria for triggering a marketing campaign for a specific customer through a form based user interface, generating monitoring criteria for monitoring customer behavior for the specific customer from the specified criteria, monitoring customer behavior according to the monitoring criteria, and triggering a marketing campaign for the specific customer only when observing customer behavior consistent with the monitoring criteria when monitoring the customer behavior. | 03-12-2009 |
Daisy Van Minde, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20150196780 | SYSTEM AND METHOD FOR RADIOTHERAPEUTIC TREATMENT - A system and method for radiotherapeutic treatment of a patient ( | 07-16-2015 |
Daisy Vanrompay, Oosterzele BE
Patent application number | Description | Published |
---|---|---|
20140242105 | VACCINES FOR CHLAMYDIA - The present invention relates to means and methods to protect against disease caused by bacteria belonging to the genus | 08-28-2014 |